PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 27, 2026Chinese Journal of Chemistry0 citations

Palladium‐Catalyzed Carbonylative 1,3‐Dialkynylation of Aliphatic Alkenes Enabled by Pyridine‐oxazoline Ligand

View Full Paper
WZWei Zhou羅羅貝雯YZYing Zhao

Key Points

  • The study aims to develop a novel palladium-catalyzed carbonylative method for 1,3-dialkynylation of alkenes.
  • Utilized palladium catalysis with pyridine-oxazoline ligands and EBX reagents
  • Conducted reactions under mild conditions with high yields and regioselectivity
  • Examined 34 examples of aliphatic alkenes yielding up to 93%
  • Achieved yields up to 93% with a variety of alkenes
  • Maintained excellent functional group tolerance and regioselectivity
  • Demonstrated efficiency in creating 1,6-diynes that can be further transformed

Abstract

Comprehensive Summary The transition metal catalyzed dialkynylation of alkenes is an attractive strategy to access variable alkynes, which have wild applications in pharmaceuticals and materials science. While documented dialkynylation methods have focused on installing alkynyl groups at 1,1‐ or 1,2‐positions, 1,3‐dialkynylation of simple alkenes remained unexplored. Herein, we developed a palladium‐catalyzed carbonylative 1,3‐dialkynylation strategy that installs two alkynyl groups onto alkenes in a single step, providing efficient access to 1,6‐diynes from readily available aliphatic alkenes and carbon monoxide (CO). This protocol operates under mild reaction conditions and exhibits excellent functional group tolerance (34 examples, yields up to 93%), high regioselectivity, and outstanding chemoselectivity. The design of pyridine‐oxazoline (PyOx) ligands in combination with EBX reagents plays a pivotal role in modulating both regioselectivity and chemoselectivity. Moreover, the 1,3‐dialkynylated products can be further transformed into various value‐added compounds through downstream synthetic manipulations.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Zhou et al. (2026) studied this question.

synapsesocial.com/papers/69eefdb5fede9185760d46bchttps://doi.org/10.1002/cjoc.70596
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Arylketone π-Conjugation Controls Enantioselectivity in Asymmetric Alkynylations Catalyzed by Centrochiral Ruthenium Complexes2018 · 33 citations
  2. 2A synthetic method for formyl→ethynyl conversion (RCHO→RCCH or RCCR′)1972 · 1,576 citations
  3. 3Dual Gold/Silver Catalysis Involving Alkynylgold(III) Intermediates Formed by Oxidative Addition and Silver‐Catalyzed C−H Activation for the Direct Alkynylation of Cyclopropenes2019 · 140 citations
  4. 4Nickel-Catalyzed Reductive 1,2-Dialkynylation of Alkenes Bearing an 8-Aminoquinoline Directing Group2019 · 44 citations
  5. 5Palladium( II )‐Catalyzed Markovnikov Hydroalkynylation of Unactivated Terminal Alkenes†2023 · 8 citations